Molecule Information
General Information of the Molecule (ID: Mol02219)
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Silicon dioxide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Pulmonary fibrosis | [1] | |||
Resistant Disease | Pulmonary fibrosis [ICD-11: CB03.1] | |||
Resistant Drug | Silicon dioxide | |||
Molecule Alteration | Up-regulation | Interaction |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | THP-1 cells | Blood | Homo sapiens (Human) | CVCL_0006 |
MRC-5 cells | Lung | Homo sapiens (Human) | CVCL_0440 | |
RAW 264.7 cells | Ascites | Mus musculus (Mouse) | CVCL_0493 | |
NIH/3T3 cells | Whole embryo | Mus musculus (Mouse) | CVCL_0594 | |
In Vivo Model | Pulmonary fibrosis miR-489 overexpression mouse model | Mus musculus | ||
Experiment for Molecule Alteration |
Overexpression assay | |||
Experiment for Drug Resistance |
Immunofluorescence assay | |||
Mechanism Description | CHRF-miR-489-MyD88 Smad3 signaling axis exerts key functions in silica-induced pulmonary fibrosis and may represent a therapeutic target for silicosis. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.